Autoinjectors Market worth $1.7 billion: Enhancing Patient Convenience and Safety in Self-Administration of Medications - Ucommune International (NASDAQ:UK)

"In May 2023, SHL Medical and MoonLake Immunotherapeutics collaborated to develop the sonelokimab autoinjector. SHL Medical's Molly autoinjector technology will be utilized for the clinical and potential commercial

Related Keywords

United States ,United Kingdom ,China ,Switzerland ,Aashish Mehra ,Moonlake Immunotherapeutics ,Eli Lilly ,Moonlake Nanobody ,Services Inc ,Abbvie Inc ,Owen Mumford Ltd ,Research Private Ltd ,Antares Pharma Inc ,Viatris Inc ,Solteam Incorporation Co Ltd ,Company Name ,Jabil Inc ,Amgen Inc ,Oval Medical Technologies Ltd ,Ypsomed Holding Ag Switzerland ,Administration Of Medications ,Sample Pages ,Market Trends ,Chronic Diseases ,Needle Phobia ,Ypsomed Holding ,West Pharmaceutical Services ,Haselmeier Gmbh ,Owen Mumford ,Oval Medical Technologies ,Elcam Drug Delivery Devices ,Antares Pharma ,Free Customization ,Research Private ,Release Distributed ,Autoinjectors Market ,Enhancing Patient Convenience ,